We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
72 hedge funds and large institutions have $287M invested in State Street SPDR S&P Pharmaceuticals ETF in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
14% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 22
12% more capital invested
Capital invested by funds: $256M → $287M (+$30.3M)
11% more funds holding
Funds holding: 65 → 72 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8.49% less ownership
Funds ownership: 72.41% → 63.93% (-8.5%)
Holders
72
Holders Change
+7
Holders Change %
+10.77%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
13
Increased
25
Reduced
22
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
U
UBS
Zurich,
Switzerland
|
+$18.2M |
| 2 |
Goldman Sachs
New York
|
+$15.9M |
| 3 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
+$9.98M |
| 4 |
Morgan Stanley
New York
|
+$8.67M |
| 5 |
LPL Financial
San Diego,
California
|
+$5.64M |
